FDA accepted sBLA for Merck’s Keytruda to treat Gastroesophageal Junction Adenocarcinoma

Junshi Biosciences’s Senaparib showed encouraging results in Ovarian cancer

NMPA accepted NDA for Junshi Biosciences’s Toripalimab for Stage 3 NSCLC in China

Sumitomo Pharma received Orphan Drug Designation for TP-1287 to treat Ewing Sarcoma